Cortical Pathology in RRMS: Taking a Cue from Four Sisters

Cortical Pathology in RRMS: Taking a Cue from Four Sisters

Background. Although grey matter pathology is a relevant aspect of multiple sclerosis (MS) both with physical and cognitive rebounds, its pathogenesis is still under investigation. To what extent the familial and sporadic cases of MS differ in cortical pathology has not been elucidated yet. Here we...

Full description

Bibliographic Details
Main Authors:	Massimiliano Calabrese, Dario Seppi, Eleonora Cocco, Valentina Poretto, Francesca Rinaldi, Paola Perini, Paolo Gallo
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Multiple Sclerosis International
Online Access:	http://dx.doi.org/10.1155/2012/760254

Similar Items

Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study
by: Francesca Rinaldi, et al.
Published: (2015-01-01)

Oral available agents in the treatment of RRMS
by: Aup&eacute;rin T
Published: (2013-10-01)

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
by: Martin Vališ, et al.
Published: (2020-05-01)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
by: E. Lesage, et al.
Published: (2010-01-01)

Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization
by: Nicola De Stefano, et al.
Published: (2021-03-01)

Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
by: Silvia Ciotti, et al.
Published: (2021-02-01)

Distributed causality in resting-state network connectivity in the acute and remitting phases of RRMS
by: Lin Wu, et al.
Published: (2020-09-01)

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
by: Tjalf Ziemssen, et al.
Published: (2017-08-01)

Structural brain network characteristics can differentiate CIS from early RRMS
by: Muthuraman eMuthuraman, et al.
Published: (2016-02-01)

Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients
by: Masoumeh Beheshti, et al.
Published: (2020-10-01)

Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis
by: Naresh Mutukula, et al.
Published: (2021-05-01)

Assessing retro-reflective markers (RRMs) usage on heavy vehicles with respect to MS 828:2011
by: Mohd Amirudin M.R, et al.
Published: (2017-01-01)

Studying the Expression of SNX2 (Sorting nexin-2) in Patients with RRMS Compared with Health Control
by: Fariba Bani Talebi Dehkordi, et al.
Published: (2017-06-01)

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients
by: Tjalf Ziemssen, et al.
Published: (2021-03-01)

SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting
by: Chiara Zecca, et al.
Published: (2020-12-01)

IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
by: Zhengjuan Lu, et al.
Published: (2020-09-01)

NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab fingolimod efficacy in multiple sclerosis
by: Marco Puthenparampil, et al.
Published: (2018-10-01)

Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
by: Feng J, et al.
Published: (2019-11-01)

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens
by: Maria Rodi, et al.
Published: (2016-08-01)

Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?
by: Jan-Patrick Stellmann, et al.
Published: (2015-01-01)

Down-Regulation Smurf2 (Smad ubiquitin Regulatory Factor 2) Gene in Patients With RRMS and Association With High Disability
by: F Behdarvand Dehkordi, et al.
Published: (2018-11-01)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
by: Monica Margoni, et al.
Published: (2021-05-01)

Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies.
by: Maria Pia Sormani, et al.
Published: (2011-01-01)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
by: Roberta Magliozzi, et al.
Published: (2021-03-01)

Evaluation of the Effect and Drug Side Effects of Fingolimod in the 3-Year Follow-up of Patients with Recurrent Form of Multiple Sclerosis (RRMS)
by: N Razazian, et al.
Published: (2020-04-01)

Sister to Sister: Becoming Literate in Relation
by: Amy Barnhill, et al.
Published: (2010-12-01)

Short-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab
by: Y. C. Wang, et al.
Published: (2011-01-01)

Sister
by: Butler, Erin
Published: (2021)

No Sisters, No Brother, No Man: “The Sisters” and Joyce’s Gnomonics
by: Purgiv F., et al.
Published: (2012-01-01)

Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
by: Guilherme Silva Julian, et al.
Published: (2020-01-01)

Sisters, secrets, subjectivities : a narrative inquiry into sistering
by: Scarlett, Christine
Published: (2011)

Sister 1982
by: Vilma Arêas
Published: (2009-12-01)

Mothers and Sisters
by: Nancy Boblett
Published: (2015-04-01)

Mothers and Sisters
by: Nancy Boblett
Published: (2013-05-01)

Sisters of shadow
by: Cleveland, Chris M.
Published: (2011)

The Boxer's Sister
by: Dummit, Sandra Sharp
Published: (2008)

Forgotten sisters
Published: ()

Brothers and Sisters
by: Macera Poli, Daniel, et al.
Published: (2013)

Sister: Poems
by: Kaplan, Liat
Published: (2017)

Older Sister
by: Gunderson, Hanna M
Published: (2016)